CLINICAL ROLE -
Kennedy Ferruggia is an assistant editor at Pharmacy Times®. She graduated from The College of New Jersey in 2023 in journalism and marketing. Prior to this position, she worked as a pharmacy associate for community pharmacies.
Study Reveals Why Some Children Still Have Asthma Attacks Even With Treatment
New research uncovers complex inflammatory pathways driving asthma flare-ups in children, highlighting the need for personalized treatment strategies.
Read More
Culturally Tailored Education Empowers Patients With Type 1 Diabetes
Simplifying complex information through illustrations and storytelling helps patients feel that managing their condition is achievable.
Expert: Independent Pharmacies Face Growing Disadvantages Under the 340B Contract Pharmacy Model
An expert shares how 340B puts independent pharmacies at a competitive disadvantage.
Study Reveals New Pathway Linked to Overactive Platelets in Type 2 Diabetes
New research uncovers a pathway linking diabetes and heightened blood clot risks, paving the way for innovative treatments to prevent cardiovascular complications.
CGM System for Weight Loss Receives FDA Clearance
Signos CGM empowers users to manage weight effectively through personalized insights and real-time glucose tracking.
Long-Term Obesity Linked to Elevated Aging Biomarkers
Long-term obesity triggers aging biomarkers in young adults, linking excess weight to accelerated biological aging and chronic health risks.
Semaglutide Receives FDA Approval for Treatment of MASH
FDA approves semaglutide for treating MASH, offering new hope for affected individuals.
RSV Vaccine Uptake Remains Low Among US Adults 60 Years and Older
RSV vaccination rates among older adults remain low despite new vaccines, highlighting disparities in uptake and the need for targeted outreach.
Weight Loss Could Aid IVF Fertility Outcomes in Women with Obesity
Weight loss before IVF enhances pregnancy chances for women with obesity, potentially improving reproductive outcomes and fertility success rates.
Ketamine-Based Drug Receives FDA Fast Track Designation for Suicidal Ideation
NRX-100 receives FDA fast track designation, offering hope for treating suicidal ideation in depression and bipolar disorder, addressing a critical health crisis.
Intranasal Insulin Shows Promising Brain Uptake Patterns in Alzheimer Disease
Intranasal insulin shows promise in targeting memory regions of the brain, offering new hope for Alzheimer disease treatment in older adults.
Researchers Evaluate Infection Control Challenges During an RSV Outbreak in a Cognitively Impaired Population
RSV poses a serious risk to older adults in long-term care, highlighting the need for effective outbreak management and infection control strategies.
Focusing on Cardiovascular Health in Childhood Shows Lifelong Benefits
Promoting heart health in children reduces obesity and chronic disease risks, ensuring better overall well-being into adulthood.
FDA Approves Expanded Indication to Tocilizumab-Anoh IV for CRS
The FDA expands tocilizumab-anoh's approval for treating cytokine release syndrome (CRS), enhancing treatment options for patients aged 2 and older.
Expert Q&A: Empowering Independent Pharmacies Through the One Voice Initiative
Brad Cochran of Cardinal Health explains the One Voice Initiative, which aims to bolster independent pharmacies.
Donanemab-azbt Demonstrated Long-Term Efficacy in Slowing Cognitive Decline
Donanemab-azbt shows sustained benefits in slowing cognitive decline in Alzheimer disease, emphasizing the value of early intervention and treatment.
Body Fat Percentage Outranks BMI as a Predictor of Long-Term Mortality
Research reveals body fat percentage and waist circumference are more accurate predictors of mortality risk than BMI, highlighting flaws in traditional weight assessments.
Noninvasive Saliva Tests Could Offer Early Clues for Diabetes and Obesity Risk
Researchers reveal that saliva tests for insulin levels offer a noninvasive method to predict type 2 diabetes and obesity risks effectively.
Inclisiran Receives FDA Approval for New Indication to Treat Hypercholesterolemia
FDA approves inclisiran as a monotherapy to effectively lower low-density lipoprotein cholesterol in adults with hypercholesterolemia, enhancing heart disease prevention strategies.
Weight Loss Drugs Show Promise in Preventing Stroke and Reducing Brain Injury Complications
New research reveals that GLP-1 receptor agonists like semaglutide may significantly reduce stroke impacts and improve recovery outcomes.
Researchers Assess Cardiovascular Outcomes in Older Adults Hospitalized With Respiratory Syncytial Virus
RSV hospitalization in older adults links to increased cardiovascular events, highlighting the need for vigilant monitoring and vaccination strategies.
Luspatercept-aamt Shows Clinically Meaningful Benefits in Reducing Transfusion Burden and Increasing Hemoglobin
Luspatercept shows promise in reducing transfusion dependence for myelofibrosis-associated anemia, despite not meeting primary trial end points.
Astegolimab Reduces COPD Exacerbations in Clinical Trials
Astegolimab shows promise in reducing chronic obstructive pulmonary disease (COPD) exacerbations, offering hope for improved management of this debilitating lung disease.
Study Evaluates Financial Implications, Socioeconomic Profile of Patients With Diabetes
A new study reveals that individuals with type 2 diabetes (T2D) face significant financial hardships, impacting their health and medication adherence.
FDA Restricts Elevidys Use Amidst New Safety Concerns
FDA places clinical hold on Sarepta's Elevidys gene therapy after safety concerns, but ambulatory patients regain access amid ongoing investigations.
Product News for July 2025
Discover groundbreaking FDA approvals for HIV prevention, targeted treatments, and OTC allergy relief, enhancing patient care and access to essential medications.
IAS 2025: Pharmacists Steer Modern HIV Care Through Coinfection Management
Experts discuss HIV management challenges, including HBV coinfections, anal cancer risks, and weight gain, highlighting innovative treatment strategies.
Lonapegsomatropin-tcgd Receives FDA Approval for Growth Hormone Deficiency
FDA approves lonapegsomatropin for once-weekly treatment of growth hormone deficiency, offering a promising alternative for improved patient adherence and outcomes.
Study Explores the Survival Advantage of GLP-1s in Cancer Patients With Diabetes
GLP-1 receptor agonists show promise in improving survival rates for older patients with cancer who have type 2 diabetes (T2D), highlighting their potential in oncology.
Global Landscape of RSV Outbreaks: Prevalence, Characteristics, and Trends
RSV outbreaks pose significant risks globally, highlighting the urgent need for targeted vaccination and treatment strategies to protect vulnerable populations.